Compounds shown to inhibit HSF1 activity, such as NZ28, were found to increase the radiosensitivity of cultured cancer cell lines, an effect that was augmented upon co-treatment with the HSP90 inhibitor NVP-AUY922 or 17AAG [150,152]. This evidence concerns the gene HSF1 and cancer.